20/08/2020 - Covid-19
The
European Commission has today concluded exploratory talks with CureVac
to purchase a potential vaccine against COVID-19. This is following the
positive steps with Sanofi-GSK on 31 July and Johnson & Johnson on
13 August and the signature of an Advance Purchase Agreement with
AstraZeneca on 14 August.
- EU strategy for COVID-19 vaccines
- EU coronavirus response
- Coronavirus: la Commissione prosegue i negoziati per ampliare il ventaglio di futuri vaccini | Italia La Commissione europea ha concluso oggi colloqui esplorativi con la società CureVac per l'acquisto di un potenziale vaccino contro la COVID-19.(...)
Post
Nessun commento:
Posta un commento